As of April 30, 2026, Cheelcare Inc. carries a market capitalization of 28.78M, placing it among publicly traded companies globally. Its enterprise value stands at 30.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 28.78M |
| Enterprise Value | 30.92M |
As of April 30, 2026, Cheelcare Inc. has 14.99M shares outstanding.
| Shares Outstanding | 14.99M |
These figures are as of April 30, 2026.
| PB Ratio | 379.72 |
| P/TBV Ratio | 524.84 |
As of April 30, 2026, Cheelcare Inc. maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.29 |
| Quick Ratio | 0.59 |
| Debt / Equity | 3,038.91 |
As of the close on July 16, 2026, Cheelcare Inc.'s stock has gained approximately 54.95% over the past 52 weeks.
| 52-Week Price Change | 54.95% |
As of April 30, 2026, Cheelcare Inc. holds 163,416.00 in cash and equivalents against 2.30M in total debt, resulting in a net debt position of 867,705.00. Total book value stands at 75,791.00, with working capital of 378,464.00 providing operational flexibility.
| Cash & Cash Equivalents | 163,416.00 |
| Total Debt | 2.30M |
| Net Debt | 867,705.00 |
| Equity (Book Value) | 75,791.00 |
| Book Value Per Share | 0.01 |
| Working Capital | 378,464.00 |
These figures cover the twelve months ended April 30, 2026.
| Capital Expenditures | -176,615.00 |
Cheelcare Inc.'s most recent stock split took place on July 16, 2025 with a 3:1 split ratio.
| Last Split Date | 7/16/2025 |
| Split Ratio | 3:1 |
Already premium?